APM Stock: Aptorum Group Gains On Phase 1 Study News

Aptorum Group APM Stock News

Aptorum Group Ltd (NASDAQ: APM) is running for the top in the market this morning, and for good reason. The company announced that Health Canada has approved the company’s application to begin a Phase 1 study. Here’s what’s happening.  Skip to What You Want to Read Aptorum Group Announces Phase 1 Study Approval Management Commentary … Read more